Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of KRAS

Myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U) is a subtype of MDS/MPN that exhibits a combination of the features of both MDS and MPN. To date, no curative treatment is available for MDS/MPN-U; however, previous studies have suggested a potential survival advantage...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: Luo, Shuna, Xu, Xiaofei, Ye, Xingnong, Zhu, Xiaoqiong, Wu, Cai, Chen, Dan, Jin, Jingxia, Zheng, Yan, Zheng, Mengli, Huang, Jian
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2020
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7553600/
https://ncbi.nlm.nih.gov/pubmed/33116596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S272207
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky